Leslie Wims Morris Joins IQVIA Board of Directors
January 24 2022 - 5:00PM
Business Wire
IQVIA (NYSE:IQV), a global provider of advanced analytics,
technology solutions, and clinical research services to the life
sciences industry, announced the appointment of Leslie Wims Morris
to its board of directors, effective today.
With more than 25 years of experience in financial services,
Wims Morris is currently Managing Director and Head of Corporate
Development for JPMorgan Chase’s Consumer & Community Banking
business, which serves more than 60 million households in the U.S.
In this role, she leads the development and launch of strategic
partnerships with leading technology, payments, e-commerce and
fintech companies and participates in firmwide strategic
initiatives. She is also a member of the firm’s investment
committee. “I am very pleased to welcome Leslie to our board of
directors,” said Ari Bousbib, chairman and CEO, IQVIA. “Her global
experience managing strategic partnerships across a wide range of
industries and deep investment expertise will provide a unique and
valuable perspective to our company.”
Wims Morris is a former Vice President of Executive Partnerships
at American Express, Senior Vice President of Strategy and Business
Development at Broadridge Financial Solutions and Senior Vice
President at Jefferies & Company. She began her career as a
Technology M&A Banker at Broadview International. During her
career she has worked with numerous global Fortune 100 companies in
the consumer retail, telecommunications, and technology industries
to develop and execute innovative partnership strategies.
Passionate about the arts, she joined the board of the Dance
Theatre of Harlem in 2010 and currently serves as Vice
Chairman.
Wims Morris holds a Master of Business Administration from the
Harvard Business School and a Bachelor of Arts in English from Yale
University.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry. IQVIA creates intelligent connections
across all aspects of healthcare through its analytics,
transformative technology, big data resources and extensive domain
expertise. IQVIA Connected Intelligence™ delivers powerful insights
with speed and agility — enabling customers to accelerate the
clinical development and commercialization of innovative medical
treatments that improve healthcare outcomes for patients. With
approximately 77,000 employees, IQVIA conducts operations in more
than 100 countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220124005821/en/
Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)
+1.973.316.3828 Tor Constantino, IQVIA Media Relations
(tor.constantino@iqvia.com) +1.484.567.6732
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jul 2023 to Jul 2024